What is the most likely diagnosis for a 56‑year‑old female presenting with polyuria, polydipsia, dry mucous membranes, poor skin turgor, orthostatic hypotension, tachycardia, weight loss, blurred vision, fasting glucose 298 mg/dL, random glucose 342 mg/dL, hemoglobin A1c 10.2 %, positive urine glucose and ketones, and elevated serum osmolality?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Suspected Diagnosis: Hyperosmolar Hyperglycemic State (HHS) with Possible Mixed DKA/HHS

This patient most likely has Hyperosmolar Hyperglycemic State (HHS), though the presence of urine ketones raises concern for a mixed DKA/HHS presentation that requires immediate emergency department evaluation and intensive care unit admission. 1, 2


CJMM Phase 1: Recognize Cues

Four Abnormal Assessment Findings:

  • Hypotension (96/60 mm Hg) with tachycardia (104 bpm) indicating significant volume depletion from osmotic diuresis 1, 2
  • Poor skin turgor and dry mucous membranes reflecting severe dehydration with estimated fluid deficit of 100-220 mL/kg (approximately 9 liters in adults) 2, 3
  • Unintentional weight loss of 12 lb in 2 months suggesting prolonged insulin deficiency and catabolic state 1
  • Blurred vision resulting from osmotic changes in the lens due to severe hyperglycemia 1

Two Abnormal Laboratory Values:

  • Random blood glucose 342 mg/dL (markedly elevated, though HHS typically presents ≥600 mg/dL; this may represent early HHS or mixed presentation) 2, 3
  • Hemoglobin A1C 10.2% indicating chronic poor glycemic control over the preceding 2-3 months 1

CJMM Phase 2: Analyze Cues

How Hyperglycemia Contributes to Polyuria and Dehydration:

Severe hyperglycemia exceeds the renal threshold for glucose reabsorption (approximately 180 mg/dL), causing glucose to spill into urine and create an osmotic gradient that prevents water reabsorption in the renal tubules. 1 This osmotic diuresis leads to massive fluid losses (100-220 mL/kg in HHS), with concurrent loss of sodium, potassium, and other electrolytes. 2 The resulting hyperosmolality (calculated as 2[Na+] + glucose/18) draws water from intracellular to extracellular compartments, worsening cellular dehydration despite initial preservation of intravascular volume. 1, 2

Relationship Between Insulin Deficiency/Resistance and Weight Loss:

Insulin deficiency or severe resistance prevents glucose utilization by peripheral tissues, forcing the body into a catabolic state where it breaks down muscle protein and adipose tissue for alternative energy sources. 1 The combination of increased hepatic and renal glucose production with impaired peripheral glucose utilization results in persistent hyperglycemia despite tissue starvation. 1 Additionally, the osmotic diuresis causes loss of calories through urinary glucose excretion (glycosuria), further contributing to weight loss. 1


CJMM Phase 3: Prioritize Hypotheses

Most Likely Health Problem:

Hyperosmolar Hyperglycemic State (HHS), potentially with mixed DKA features given the presence of urine ketones. 1, 2 The clinical presentation of polyuria, polydipsia, weight loss developing over weeks, severe dehydration, and marked hyperglycemia with A1C 10.2% is classic for HHS in a middle-aged adult with type 2 diabetes. 1, 2 However, the presence of urine ketones requires urgent assessment of serum ketones (β-hydroxybutyrate preferred), arterial pH, and bicarbonate to rule out concurrent DKA, as up to one-third of patients present with mixed features. 4, 5

One Acute Complication at Risk:

Vascular thrombotic events (deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction) due to severe hyperosmolality and hyperviscosity from profound dehydration. 2, 3 HHS carries mortality rates up to 15%, significantly higher than DKA, with thrombotic complications being a major contributor. 2, 6

Priority Concern at This Time:

Hemodynamic instability from severe volume depletion evidenced by hypotension (96/60 mm Hg), tachycardia (104 bpm), and clinical signs of dehydration. 1, 2 This requires immediate aggressive fluid resuscitation to restore circulating volume and prevent cardiovascular collapse, acute kidney injury, and thrombotic events. 2, 3


CJMM Phase 4: Generate Solutions

Two Priority Nursing Interventions:

  1. Establish large-bore IV access immediately and initiate rapid isotonic saline (0.9% NaCl) infusion at 15-20 mL/kg/hour (approximately 1-1.5 L in first hour for this patient). 2, 3 Fluid resuscitation is the cornerstone of HHS management and takes priority over insulin administration. 4

  2. Obtain STAT laboratory studies including: serum electrolytes with calculated anion gap, arterial or venous blood gas for pH and bicarbonate, serum β-hydroxybutyrate (preferred over urine ketones), serum osmolality, BUN, creatinine, complete blood count, and ECG. 1, 2 These are essential to confirm HHS diagnosis (osmolality ≥320 mOsm/kg, pH ≥7.30, bicarbonate ≥15 mEq/L, ketones ≤3.0 mmol/L), differentiate from DKA, and guide electrolyte replacement. 2, 3

Anticipated Medications or Treatments:

  • IV 0.9% sodium chloride for aggressive volume repletion with goal to correct estimated 9-liter deficit within 24 hours, monitoring for fluid overload especially given age >50 years 2, 3
  • Delay insulin therapy until glucose stops falling with IV fluids alone (unless significant ketonemia is present), then initiate IV regular insulin at 0.1 units/kg/hour without bolus 2, 3
  • Potassium replacement at 20-30 mEq/L (2/3 KCl, 1/3 KPO₄) once renal function confirmed and serum K+ known; hold insulin if K+ <3.3 mEq/L until corrected 2
  • Dextrose 5% or 10% added to 0.45% saline when glucose reaches 250-300 mg/dL to prevent overly rapid glucose decline while maintaining insulin infusion at reduced rate (0.05-0.1 units/kg/hour) 2

CJMM Phase 5: Take Action

Immediate Nursing Actions Required:

  1. Transfer patient to emergency department immediately for ICU-level care, as HHS requires intensive monitoring with mortality rates up to 15% and risk of life-threatening complications. 2, 3, 6

  2. Establish continuous cardiac monitoring and hourly vital signs to detect arrhythmias from electrolyte shifts and monitor hemodynamic response to fluid resuscitation. 2

  3. Insert Foley catheter for strict intake/output monitoring with goal urine output ≥0.5 mL/kg/hour as marker of adequate renal perfusion. 3

  4. Draw blood every 2-4 hours to monitor glucose, electrolytes, osmolality, and venous pH to guide therapy adjustments and ensure osmolality reduction does not exceed 3-8 mOsm/kg/hour (critical to prevent cerebral edema and central pontine myelinolysis). 2

  5. Calculate corrected sodium by adding 1.6 mEq/L for each 100 mg/dL glucose elevation above 100 mg/dL, and calculate effective osmolality as 2[Na+] + glucose/18 to accurately track treatment response. 2

  6. Initiate VTE prophylaxis given extreme hypercoagulability from hyperosmolality and dehydration. 3

Patient Education to Begin Today:

  • Explain that this is a life-threatening diabetic emergency requiring hospitalization and that she likely has type 2 diabetes (given age, presentation, and A1C 10.2%). 1, 2

  • Teach recognition of warning signs: excessive thirst, frequent urination, unexplained weight loss, weakness, and blurred vision require immediate medical attention before progression to crisis. 1

  • Emphasize that infection is the most common trigger for HHS; any fever, cough, urinary symptoms, or wounds must prompt immediate glucose monitoring and medical evaluation. 1, 2

  • Stress the importance of maintaining hydration during illness and never stopping diabetes medications without medical guidance. 1

  • Discuss that certain medications (corticosteroids, thiazide diuretics, SGLT2 inhibitors) can precipitate hyperglycemic crises and require close monitoring. 2


CJMM Phase 6: Evaluate Outcomes

Findings Indicating Improvement:

  • Effective serum osmolality decreasing at 3-8 mOsm/kg/hour toward goal <300 mOsm/kg without exceeding maximum safe reduction rate 2, 3
  • Blood pressure normalizing (systolic >100 mm Hg) with heart rate <100 bpm indicating restored circulating volume 2
  • Urine output ≥0.5 mL/kg/hour demonstrating adequate renal perfusion 3
  • Mental status returning to baseline alertness as hyperosmolality resolves 2, 3
  • Blood glucose declining at 50-75 mg/dL/hour toward target of 250-300 mg/dL in first 24 hours 2
  • Resolution criteria met: osmolality <300 mOsm/kg, hypovolemia corrected, cognitive status at pre-morbid baseline, glucose <270 mg/dL 2, 3

Findings Requiring Urgent Reevaluation:

  • Osmolality decreasing >8 mOsm/kg/hour indicating excessive correction rate with risk of cerebral edema or central pontine myelinolysis (70% mortality once clinical symptoms develop) 2
  • Worsening mental status, new headache, or seizures suggesting cerebral edema from overly rapid osmolality correction 2
  • Serum potassium <3.3 mEq/L requiring immediate insulin hold and aggressive potassium replacement to prevent life-threatening arrhythmias 2
  • Glucose falling >75 mg/dL/hour or dropping below 250 mg/dL before osmolality corrected necessitating dextrose addition and insulin rate reduction 2
  • Development of pulmonary rales or respiratory distress indicating fluid overload, particularly concerning in patients >50 years 2
  • Persistent hypotension despite 2-3 liters fluid resuscitation suggesting septic shock, myocardial infarction, or other precipitating acute illness requiring additional workup 1, 2
  • Anion gap >12 mEq/L with pH <7.30 or bicarbonate <15 mEq/L confirming mixed DKA/HHS requiring modified treatment approach with earlier insulin initiation 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperosmolar Hyperglycemic State Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diabetic ketoacidosis.

Nature reviews. Disease primers, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.